tiprankstipranks
Trending News
More News >
ImageneBio (IMA)
NASDAQ:IMA
US Market

ImageneBio (IMA) Income Statement

Compare
108 Followers

ImageneBio Income Statement

Last quarter (Q3 2025), ImageneBio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, ImageneBio's net income was $-24.78M. See ImageneBio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 3.50M$ 9.16M$ 15.62M$ 30.98M$ 9.19M
Gross Profit
$ 3.50M$ 8.14M$ -48.70M$ -16.12M$ -35.65M
Operating Expenses
$ 40.50M$ 83.56M$ 22.20M$ 18.02M$ 8.87M
Depreciation and Amortization
$ 1.53M$ 1.02M$ 751.00K$ 544.00K$ 300.00K
EBITDA
$ -35.47M$ -74.40M$ -70.15M$ -33.59M$ -44.22M
Operating Income
$ -37.00M$ -75.42M$ -70.90M$ -34.14M$ -44.52M
Other Income/Expenses
$ 445.00K$ 7.09M$ 2.14M$ 23.00K$ 263.00K
Pretax Income
$ -36.55M$ -68.33M$ -68.77M$ -34.12M$ -44.26M
Net Income
$ -36.57M$ -68.17M$ -68.77M$ -34.12M$ -44.26M
Per Share Metrics
Basic EPS
$ -1.02$ -1.63$ -1.90$ -0.95$ -3.16
Diluted EPS
$ -1.02$ -1.63$ -1.90$ -0.95$ -3.16
Weighted Average Shares Outstanding
48.26M 41.74M 36.19M 35.98M 13.99M
Weighted Average Shares Outstanding (Diluted)
48.26M 41.74M 36.19M 35.98M 13.99M
Currency in USD

ImageneBio Earnings and Revenue History